Exchange: NASDAQ·Updated 06:23 PM EDT
TPST logo

TPSTTempest Therapeutics Inc

$1.09
$0.02
(1.80%)
Today
Closed $1.09
$0.0069
(0.63%)
After Hours
EarningsAug 11
Mkt Cap$17.42M
Vol81,787.00

About

Tempest Therapeutics, Inc. is a clinical-stage oncology company advancing a diverse portfolio of small molecule product candidates containing tumor-targeted and/or immune-mediated mechanisms with the potential to treat a wide range of tumors. The company’s novel programs range from early research to later-stage investigation in a randomized global study in first-line cancer patients. Tempest Therapeutics was founded in 2011 and is headquartered in Brisbane, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
4

Frequently Asked Questions

What is Market Cap of Tempest Therapeutics Inc?
What is the 52-week high for Tempest Therapeutics Inc?
What is the 52-week low for Tempest Therapeutics Inc?
What is Tempest Therapeutics Inc stock price today?
What was Tempest Therapeutics Inc stock price yesterday?
What is the PE ratio of Tempest Therapeutics Inc?
What is the Price-to-Book ratio of Tempest Therapeutics Inc?
What is the 50-day moving average of Tempest Therapeutics Inc?
How many employees does Tempest Therapeutics Inc have?

Advertisement|Remove ads.